Fantastic news! - potential for IHL -675A to become a multi use medication. I think the market for this potential med has been expanded significantly with this new area of application. Key takeout for me is that we are seeing efficacy beyond respiratory conditions, so the probability of 675 A being a real "discovery" has gone up even further as well as an extended global market. This is one of the most significant Ann to date I think.
IHL continues to forge ahead successfully with breakthrough R&D - great work by the team! Pity the sellers, you never know what is around the corner...
- Forums
- ASX - By Stock
- IHL
- Ann: Trading Halt
Ann: Trading Halt, page-188
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online